FDA Investigator

Justin A Boyd

Latest inspection on record: Pilar, Argentina, June 2026 · records back to 2008

Human DrugsFoods & CosmeticsBiologicsAnimal Drugs & FeedsMedical Devices & Rad Health

FDA inspection record · Last updated August 15, 2026

Overview

  • 279 inspections across 240 sites are on record.
  • 1374 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-09.

At a glance

Inspections

279

Sites

240

Observations

1,374

Career since

Aug 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Umicore Argentina S.A.9 Jun 2026Human DrugsOn file
Fresenius Medical Care Andina S.A.S.2 Jun 2026Human DrugsView 483 →
Hanlim Pharm Co. Ltd.24 Apr 2026Human DrugsView 483 →
Rohto-Mentholatum (Vietnam) Co., Ltd.14 Apr 2026Human DrugsView 483 →
Excel Vision22 Jan 2026Human DrugsView 483 →

Sites inspected

Umicore Argentina S.A.Pilar, Argentina1 insp.
Hanlim Pharm Co. Ltd.Yongin, Korea (the Republic of)1 insp.
Rohto-Mentholatum (Vietnam) Co., Ltd.Ho Chi Minh, Vietnam1 insp.
Excel VisionAnnonay, France1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Justin A Boyd's 1,374 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site